Literature DB >> 6746100

Extracellular phospholipase A2 and lysophospholipase produced by Vibrio vulnificus.

J Testa, L W Daniel, A S Kreger.   

Abstract

Phospholipase A2 and lysophospholipase activities were detected in the culture supernatant fluids of a virulent strain of Vibrio vulnificus. The phospholipase A2 was inactivated by heating at 56 degrees C for 30 min, had an apparent molecular weight of greater than or equal to 80,000 (estimated by gel filtration with Sephadex G-75), and a pI of ca. 5.0. Phospholipid hydrolysis was unaffected by Ca2+ or ethylene glycol-bis(beta-aminoethyl ether)-N,N-tetraacetic acid and was optimal at pH 5.0 to 5.5. The lysophospholipase was not affected by heating at 56 degrees C for 30 min but was inactivated at 100 degrees C and had an apparent molecular weight of greater than or equal to 80,000 and a pI of ca. 4.0. The enzymes were detected coincidentally with a previously described extracellular cytolysin of V. vulnificus; however, they were physically separable from the toxin (which did not possess phospholipase A, C, or D activity) by gel filtration with Sephadex G-75.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6746100      PMCID: PMC263259          DOI: 10.1128/iai.45.2.458-463.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Phospholipase C assay using p-nitrophenylphosphoryl-choline together with sorbitol and its application to studying the metal and detergent requirement of the enzyme.

Authors:  S Kurioka; M Matsuda
Journal:  Anal Biochem       Date:  1976-09       Impact factor: 3.365

Review 2.  Biology of the marine enterobacteria: genera Beneckea and Photobacterium.

Authors:  P Baumann; L Baumann
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

3.  Source of arachidonic acid for prostaglandin synthesis in Madin-Darby canine kidney cells.

Authors:  L W Daniel; L King; M Waite
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

4.  A novel purification procedure for Penicillium notatum phospholipase B and evidence for a modification of phospholipase B activity by the action of an endogenous protease.

Authors:  T Okumura; S Kimura; K Saito
Journal:  Biochim Biophys Acta       Date:  1980-02-22

5.  Vibrio ("Beneckea") vulnificus, the bacterium associated with sepsis, septicaemia, and the sea.

Authors:  J J Farmer
Journal:  Lancet       Date:  1979-10-27       Impact factor: 79.321

6.  Purification and partial characterization of a bacterial phospholipid: cholesterol acyltransferase.

Authors:  J T Buckley; L N Halasa; S MacIntyre
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

7.  Halophilic vibrios from human tissue infections on the pacific coast of Australia.

Authors:  H K Ghosh; T E Bowen
Journal:  Pathology       Date:  1980-07       Impact factor: 5.306

8.  Lactose-positive Vibrio in seawater: a cause of pneumonia and septicemia in a drowning victim.

Authors:  M T Kelly; D M Avery
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

9.  Phospholipid synthesis in human embryo fibroblasts infected with herpes simplex virus type 2.

Authors:  L W Daniel; M Waite; L S Kucera; L King; I Edwards
Journal:  Lipids       Date:  1981-09       Impact factor: 1.880

10.  Detection of extracellular toxin(s) produced by Vibrio vulnificus.

Authors:  A Kreger; D Lockwood
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

View more
  30 in total

1.  Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin.

Authors:  J J Fan; C P Shao; Y C Ho; C K Yu; L I Hor
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

2.  Role of flagellum and motility in pathogenesis of Vibrio vulnificus.

Authors:  Jong-Ho Lee; Jong Bok Rho; Kyung-Je Park; Chang Beom Kim; Yang-Soo Han; Sang Ho Choi; Kyu-Ho Lee; Soon-Jung Park
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

3.  Cloning and sequence analysis of a novel hemolysin gene (vllY) from Vibrio vulnificus.

Authors:  T M Chang; Y C Chuang; J H Su; M C Chang
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

4.  Overexpression, purification, characterization, and pathogenicity of Vibrio harveyi hemolysin VHH.

Authors:  Yingbin Zhong; Xiao-Hua Zhang; Jixiang Chen; Zhenghao Chi; Boguang Sun; Yun Li; Brian Austin
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene.

Authors:  K Yamamoto; A C Wright; J B Kaper; J G Morris
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

6.  Ubiquitin activates patatin-like phospholipases from multiple bacterial species.

Authors:  David M Anderson; Hiromi Sato; Aaron T Dirck; Jimmy B Feix; Dara W Frank
Journal:  J Bacteriol       Date:  2014-11-17       Impact factor: 3.490

7.  Regulation of metalloprotease gene expression in Vibrio vulnificus by a Vibrio harveyi LuxR homologue.

Authors:  C P Shao; L I Hor
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

8.  A calcium-calmodulin antagonist blocks experimental Vibrio vulnificus cytolysin-induced lethality in an experimental mouse model.

Authors:  Young-Rae Lee; Kwang-Hyun Park; Zhao-Zhen Lin; Young-Jong Kho; Jin-Woo Park; Hye-Won Rho; Bon-Sun Koo; Hyung-Rho Kim; Eun-Kyung Song; Hong-Nu Yu; Myung-Kwan Han; Seung-Ok Lee; Eun-Chung Jhee; Jong-Suk Kim
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice.

Authors:  A C Wright; J G Morris
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  Identification and Verification of Ubiquitin-Activated Bacterial Phospholipases.

Authors:  Maxx H Tessmer; David M Anderson; Adam M Pickrum; Molly O Riegert; Dara W Frank
Journal:  J Bacteriol       Date:  2019-01-28       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.